Search

Your search keyword '"Collins, R."' showing total 4 results
Start Over Author "Collins, R." Topic myelodysplastic syndromes Publisher elsevier b.v.
4 results on '"Collins, R."'

1. P034 - Topic: AS04-MDS Biology and Pathogenesis/AS04a-Normal, MDS, and leukemic stem cells: ULTRA-LOW INPUT SEQUENCING TO IDENTIFIES TRANSPLANT RESISTANT STEM CELLS IN MYELODYSPLASTIC SYNDROMES.

Author

Kroger, B., Huang, Y., Patel, P., Afrough, A., Kaur, G., Anderson, L., Awan, F., Ramakrishnan, P., Verma, K., Vittrup, R., Collins, R., Vusirikala, M., Madanat, Y., Maciejewski, J., Gurani, C., Tamari, R., and Chung, S.

Subjects
*STEM cell transplantation, *MYELODYSPLASTIC syndromes, *STEM cells, *PRELEUKEMIA, *BIOLOGY
Published
2023
Full Text
View/download PDF

2. 38 - Enasidenib (AG-221), A Selective Oral Inhibitor of Mutant Isocitrate Dehydrogenase 2 (IDH2) Enzyme, In Patients with Myelodysplastic Syndromes (MDS).

Author

Stein, E.M., Fathi, A.T., DiNardo, C.D., Pollyea, D.A., Swords, R.T., Roboz, G.J., Collins, R., Sekeres, M.A., Stone, R.M., Attar, E.C., Tosolini, A., Xu, Q., Amatangelo, M., Gupta, I., Knight, R.D., de Botton, S., Tallman, M.S., and Kantarjian, H.M.

Subjects
*MYELODYSPLASTIC syndromes, *ISOCITRATE dehydrogenase, *PATIENTS
Published
2017
Full Text
View/download PDF

3. 88 BONE MARROW BLAST (BMBL) RESPONSE CORRELATES WITH OVERALL SURVIVAL IN RIGOSERTIB-TREATED PATIENTS WITH HIGHER-RISK MDS AFTER FAILURE OF HYPOMETHYLATING AGENTS (HMAS): A NEW RESPONSE CRITERION?

Author

Silverman, L.R., Fenaux, P., Al-Kali, A., Baer, M.R., Sekeres, M., Roboz, G., Gaidano, G., Scott, B., Greenberg, P., Platzbecker, U., Steensma, D.P., Kambhampati, S., Kreuzer, K.A., Godley, L., Collins, R., Atallah, E., Navada, S.C., Azarnia, N., and Garcia-Manero, G.

Subjects
*MYELODYSPLASTIC syndromes, *5Q deletion syndrome, *PRELEUKEMIA, *LEUKEMIA, *LEUKEMIA treatment, *LEUKEMIA diagnosis, *MEDICAL care
Published
2015
Full Text
View/download PDF

4. 112 RANDOMIZED PHASE III STUDY OF IV RIGOSERTIB VERSUS BEST SUPPORTIVE CARE (BSC) IN PATIENTS WITH HIGHER-RISK MDS (HR-MDS) AFTER FAILURE OF HYPOMETHYLATING AGENTS (HMAS).

Author

Garcia-Manero, G., Fenaux, P., Al-Kali, A., Baer, M.R., Sekeres, M., Roboz, G., Gaidano, G., Scott, B., Greenberg, P., Platzbecker, U., Steensma, D.P., Kambhampati, S., Kreuzer, K.A., Godley, L., Collins, R., Atallah, E., Azarnia, N., Petrone, M.E., Snyder, B.R., and Maniar, M.

Subjects
*MYELODYSPLASTIC syndromes, *LEUKEMIA treatment, *PRELEUKEMIA, *LEUKEMIA, *LEUKEMIA diagnosis, *MEDICAL care
Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results